Evidence map›Paper›PMID 19667113›Full record

SynthesisArteriosclerosis, thrombosis, and vascular biology2009

A common variant in low-density lipoprotein receptor-related protein 6 gene (LRP6) is associated with LDL-cholesterol.

Maciej Tomaszewski, Fadi J Charchar, Timothy Barnes, Magdalena Gawron-Kiszka, Agnieszka Sedkowska, Ewa Podolecka, Jacek Kowalczyk, Wendy Rathbone, Zbigniew Kalarus, Wladyslaw Grzeszczak and 3 more

Registry-linked trialOpen access · greenAbstract readMeta-AnalysisMulticenter Study
In one paragraph

Synthesis in Arteriosclerosis, thrombosis, and vascular biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01753245 (CARDIOVASCULAR RISK FACTORS IN A SPANISH POPULATION OF PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS VULGARIS, WITH OR WITHOUT ARTHRITIS, TREATED WITH ANTI-TNF IN REAL CLINICAL PRACTICE. ANALYSIS OF THE INFLUENCE OF METABOLIC SYNDROME ON TREATMENT EFFICACY.), which is not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01753245 unknown statusnot on this mapstarted 2012, after this paper: background citation

Cardiovascular risk factors in a spanish population of patients with moderate-to-severe psoriasis vulgaris, with or without arthritis, treated with anti-tnf in real clinical practice. analysis of the influence of metabolic syndrome on treatment efficacy.

TypeobservationalSponsorJuan RuanoRan2012 to 2014Enrolled300ConditionsPsoriasis Vulgaris, Metabolic Syndrome
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Renal Mechanisms of Association between Fibroblast Growth Factor 1 and Blood Pressure.Journal of the American Society of Nephrology : JASN · 2015
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. LRPs in WNT Signalling.Handbook of experimental pharmacology · 2021
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Maciej TomaszewskiDepartment of Cardiovascular Sciences, University of Leicester, Clinical Sciences Wing, Glenfield Hospital, Leicester, LE3 9QP, UK. mt142@le.ac.uk
Fadi J Charchar
Timothy Barnes
Magdalena Gawron-Kiszka
Agnieszka Sedkowska
Ewa Podolecka
Jacek Kowalczyk
Wendy Rathbone
Zbigniew Kalarus
Wladyslaw Grzeszczak
Alison H Goodall
Nilesh J Samani
Ewa Zukowska-Szczechowska
Federation University · AUUniversity of Leicester · GB

Funding

Association between the Y chromosome and androgensR03TW007165 · FIC · GEORGETOWN UNIVERSITY · PI SANDBERG, KATHRYN L · 2005 to 2007
$104k
British Heart Foundation PG/06/097FIC NIH HHS R03 TW007165
6 · The paper itself

Abstract

objectiveA rare mutation in low-density lipoprotein receptor-related protein 6 gene (LRP6) was identified as the primary molecular defect underlying monogenic form of coronary artery disease. We hypothesized that common variants in LRP6 could predispose subjects to elevated LDL-cholesterol (LDL-C). METHODS AND

resultsTwelve common (minor allele frequency > or =0.1) single nucleotide polymorphisms in LRP6 were genotyped in 703 individuals from 213 Polish pedigrees (Silesian Cardiovascular Study families). The family-based analysis revealed that the minor allele of rs10845493 clustered with elevated LDL-C in offspring more frequently than expected by chance (P=0.0053). The quantitative analysis restricted to subjects free of lipid-lowering treatment confirmed the association between rs10845493 and age-, sex-, and BMI-adjusted circulating levels of LDL-C in families as well as 2 additional populations - 218 unrelated subjects from Silesian Cardiovascular Study replication panel and 1138 individuals from Young Men Cardiovascular Association cohort (P=0.0268, P=0.0476, and P=0.0472, respectively). In the inverse variance weighted meta-analysis of the 3 populations each extra minor allele copy of rs10845493 was associated with 0.14 mmol/L increase in age-, sex-, and BMI-adjusted LDL-C (SE=0.05, P=0.0038).

conclusionsCommon polymorphism in the gene underlying monogenic form of coronary artery disease impacts on risk of LDL-C elevation.

Indexed as

Polymorphism, Single NucleotideAdultCholesterol, LDLCoronary Artery DiseaseDyslipidemiasFemaleGene FrequencyGenetic Predisposition to DiseaseHumansLDL-Receptor Related ProteinsLipid MetabolismLow Density Lipoprotein Receptor-Related Protein-6MaleMiddle AgedMonocytesPedigreeCholesterol, LDLLDL-Receptor Related ProteinsLow Density Lipoprotein Receptor-Related Protein-6LRP6 protein, humanRNA, Messenger

Identifiers

PMID19667113
PMCPMC2814817
OpenAlexW1966555281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.